Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
268.67 USD | -1.55% |
|
+3.07% | +13.13% |
Feb. 12 | C Worldwide Healthcare Select up 5.8% in January - divests Illumina | FW |
Jan. 17 | William O'Neil Initiates Penumbra at Buy | MT |
Chart calendar Penumbra, Inc.
Upcoming events on Penumbra, Inc.
Past events on Penumbra, Inc.
2025-01-13 06:00 pm | JP Morgan Healthcare Conference |
2024-12-04 08:00 am | Piper Sandler Healthcare Conference |
2024-10-30 04:30 pm | Q3 2024 Earnings Call |
2024-10-30 04:05 pm | Q3 2024 Earnings Release |
2024-09-10 09:05 am | Baird Global Healthcare Conference |
2024-09-04 02:15 pm | Wells Fargo Healthcare Conference |
2024-08-13 09:00 am | CG Growth Conference |
2024-07-30 04:30 pm | Q2 2024 Earnings Call |
2024-07-30 04:05 pm | Q2 2024 Earnings Release |
2024-06-18 10:05 am | Truist Securities MedTech Conference |
2024-06-06 12:20 pm | William Blair Growth Stock Conference |
2024-06-05 02:00 pm | Annual General Meeting |
2024-05-15 08:00 am | RBC Capital Markets Global Healthcare Conference |
2024-05-07 04:30 pm | Q1 2024 Earnings Call |
2024-05-07 04:05 pm | Q1 2024 Earnings Release |
2024-02-22 04:30 pm | Q4 2023 Earnings Call |
2024-02-22 04:05 pm | Q4 2023 Earnings Release |
2024-01-08 11:15 am | JPMorgan Healthcare Conference |
2023-11-28 01:30 pm | Piper Sandler Healthcare Conference |
2023-11-02 04:30 pm | Q3 2023 Earnings Call |
Annual results
Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 748 738 1.3% | 847 845 0.26% | 1 059 1 061 -0.2% | 1 191 | 1 362 | 1 556 |
EBITDA Million USD | Released Forecast Spread | 51,5 62,4 -17.49% | 38,7 37,7 2.71% | 129 122 5.47% | 155 | 226 | 275 |
EBIT Million USD | Released Forecast Spread | 35,0 41,7 -16.05% | 14,4 14,1 2.5% | 101 98,2 3.12% | 134 | 180 | 239 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -10,5 11,4 -192.53% | 3,89 5,86 -33.62% | 79,7 84,6 -5.87% | 22,7 | 182 | 240 |
Net income Million USD | Released Forecast Spread | 5,28 16,3 -67.58% | -2,00 5,12 -139.11% | 91,0 71,8 26.61% | 15,9 | 146 | 192 |
EPS USD | Released Forecast Spread | 0,14 0,44 -67.82% | -0,05 0,13 -137.74% | 2,32 1,85 25.45% | 0,42 | 3,76 | 4,92 |
Announcement Date | 22/02/22 | 23/02/23 | 22/02/24 | - |
Quarterly results
Fiscal Period | September | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 241 230 5.09% | 261 253 3.26% | 271 265 2.19% | 285 287 -0.65% | 279 275 1.51% | 299 298 0.5% | 301 297 1.23% | 312 | 317 | 337 | 345 | 360 | 365 | 388 | 392 |
EBITDA Million USD | Released Forecast Spread | 17,0 14,1 20.17% | 27,0 22,6 19.36% | 40,2 30,2 33.03% | 44,4 41,6 6.89% | 26,8 25,7 4.19% | 39,4 36,3 8.34% | 44,5 44,0 1.02% | 52,3 | 42,3 | 49,1 | 54,7 | 58,3 | |||
EBIT Million USD | Released Forecast Spread | 10,4 5,93 75.14% | 20,3 13,6 49.11% | 33,2 21,8 52.4% | 37,4 35,1 6.73% | 19,3 17,0 13.79% | 31,7 27,1 17.09% | 40,3 33,0 22.19% | 42,9 | 34,4 | 42,3 | 47,8 | 53,2 | 44,5 | 52,8 | 61,5 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 8,65 5,50 57.19% | 19,5 13,5 44.74% | 13,3 20,5 -35.2% | 38,2 33,6 13.52% | 14,6 18,1 -19.33% | -77,9 26,8 -390.45% | 39,8 33,6 18.44% | 45,0 | 38,8 | 44,2 | 48,6 | 52,4 | 54,8 | 60,3 | 62,0 |
Net income Million USD | Released Forecast Spread | 8,56 4,36 96.59% | 19,0 10,9 74.41% | 9,21 16,2 -42.95% | 54,2 27,4 97.86% | 11,0 12,3 -10.27% | -60,2 21,0 -386.95% | 29,5 26,8 10% | 34,7 | 30,6 | 35,8 | 39,7 | 43,7 | 40,1 | 45,8 | 50,1 |
EPS USD | Released Forecast Spread | 0,22 0,11 96.69% | 0,48 0,28 72.57% | 0,23 0,43 -45.9% | 1,38 0,71 93.64% | 0,28 0,31 -9.98% | -1,55 0,54 -388.47% | 0,75 0,71 6.01% | 0,90 | 0,75 | 0,90 | 1,01 | 1,12 | 1,02 | 1,16 | 1,27 |
Announcement Date | 02/05/23 | 01/08/23 | 02/11/23 | 22/02/24 | 07/05/24 | 30/07/24 | 30/10/24 | - | - | - | - | - | - | - | - |
2025-02-18 04:01 pm | SEMLER SCIENTIFIC, INC.: Q4 2024 Earnings Release |
2025-02-18 04:05 pm | PENUMBRA, INC.: Q4 2024 Earnings Release |
2025-02-24 04:09 pm | SI-BONE, INC.: Q4 2024 Earnings Release |
2025-02-25 04:05 pm | MASIMO CORPORATION: Q4 2024 Earnings Release |
2025-02-27 07:00 am | NOVOCURE LIMITED: Q4 2024 Earnings Release |
2025-02-27 04:05 pm | TREACE MEDICAL CONCEPTS, INC.: Q4 2024 Earnings Release |
2025-03-03 | INARI MEDICAL, INC.: Q4 2024 Earnings Release (Projected) |
2025-03-26 | SHANDONG WEIGAO ORTHOPAEDIC DEVICE CO., LTD: Q4 2024 Earnings Release |
2025-04-21 | GETINGE AB: Q1 2025 Earnings Release |
2025-04-22 | APT MEDICAL INC.: Q4 2024 Earnings Release |
Past sector events for Penumbra, Inc.
2025-02-14 02:00 am | IMPLANTICA AG: Q4 2024 Earnings Release |
2025-02-13 | ASAHI INTECC CO., LTD.: Q2 2025 Earnings Release |
2025-02-04 | CHEMOMETEC A/S: Q2 2025 Earnings Release |
2025-01-28 02:00 am | GETINGE AB: Q4 2024 Earnings Release |
2024-11-15 02:00 am | IMPLANTICA AG: Q3 2024 Earnings Release |
2024-11-13 | ASAHI INTECC CO., LTD.: Q1 2025 Earnings Release |
2024-11-12 04:09 pm | SI-BONE, INC.: Q3 2024 Earnings Release |
2024-11-07 11:12 am | CHEMOMETEC A/S: Q1 2025 Sales and Revenue Release - Trading Statement |
2024-11-05 04:05 pm | MASIMO CORPORATION: Q3 2024 Earnings Release |
2024-10-30 | SHANDONG WEIGAO ORTHOPAEDIC DEVICE CO., LTD: Q3 2024 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PEN Stock
- Calendar Penumbra, Inc.